A plethora of research data showed that decreased levels of complement C3 may result in impaired immunological responses, consequently leading to reduced clearance of plaques in the AD‐prone brain, thus offering a plausible explanation of the phenomenon [11, 39, 40]. Here, C3 is linked to Alzheimer disease.